The Valley Desk

ArticleBMJ openPublished

Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
BMJ open
Published
Subject terms
Humans; Antipsychotic Agents; Delayed-Action Preparations; Treatment Outcome; Injections, Intramuscular; Drug Administration Schedule; Schizophrenia; Adolescent; Adult; Rwanda; Female; Male
PubMed ID
42303401
PubMed Central ID
PMC13288876
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal